Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace

General-purpose reagents, 2/14

February 2014—Life Technologies released general-purpose reagents (GPRs) for the development of molecular diagnostic assays based on qPCR and capillary electrophoresis (CE). GPR products are for laboratory use and come with a higher quality assurance than research-use-only products. For CE (for sequencing and fragment analysis), BigDye Terminator Cycle Sequencing Reagents provide the required components for cycle sequencing reactions in a premixed format. They are optimized for longer, higher-quality reads with uniform peak heights and optimal signal balance and are appropriate for a range of applications, including de novo sequencing and resequencing.

Test predicts response to cisplatin treatment, 2/14

February 2014—Myriad Genetics presented clinical data from a research study showing that its HRD (homologous recombination deficiency) test predicted platinum response in patients with triple-negative breast cancer (P=0.0003). The HRD score predicted, with a sensitivity of 100 percent, all of the patients who experienced a complete response after presurgical treatment with platinum. In addition, the results showed that the HRD score was generalizable across all breast cancer subtypes.

Ductless fume hoods, 1/14

January 2014—Air Science introduced its new Purair Eco line of energy-saving ductless fume hoods designed for chemical and particulate protection over a broad range of laboratory and industrial applications.

ICE COLD-PCR analysis presented, 1/14

January 2014—Transgenomic in October announced the results of a research collaboration with MD Anderson Cancer Center employing the company’s ICE COLD-PCR platform. This interim analysis demonstrates that in a high percentage of patients with advanced cancers, the same genetic mutations were detected in cell-free DNA present in the blood as were originally found in primary tumors. In a subset of patients followed over time, detection of mutations in cfDNA correlated with response to therapy or disease progression.

Freezerworks Unlimited upgrade, 1/14

January 2014—Dataworks Development released an upgrade, version 6.0, to its Freezerworks Unlimited freezer inventory and sample management software program. Expanded configurability in version 6.0 is most notable with improvements and greater capabilities in screen design and layout, as well as in adapting the shipping processes to the workflow of the lab, biobank, and repository. The report writer has been redesigned to offer a more user-friendly interface for developing and printing reports, while adding flexibility for subtotaling and inventory counts. Users can also bar code any data field on a report for quick and accurate accessing of sample records and data.

RFID-enabled pipettes, 1/14

January 2014—Mettler Toledo has embedded radio- frequency identification tags in all of its premium Rainin air displacement pipettes, including its recently released E4 XLS electronic model. RFID tagging helps labs establish advanced calibration schedules through heightened pipette tracking.

3D surgical microscopes, 1/14

January 2014—The first 3D surgical microscopes from Leica Microsystems with TrueVision 3D technology inside are now available to customers. By incorporating the digital smart 3D system inside select models of Leica’s surgical microscopes, Leica and TruVision have eliminated the need for a separate 3D cart.

MPLN acquires MiSeqDx, 1/14

January 2014—Molecular Pathology Laboratory Network has acquired the Illumina MiSeqDx and will use the system to expand testing across all of its clinical laboratories, including its clinical trials group Geneuity Clinical Research Services. MPLN is a molecular reference laboratory specializing in oncology, women’s health, and clinical research services.

MARKETPLACE

TRENDING